BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3314435)

  • 1. Fibrocystic breast disease.
    Scott EB
    Am Fam Physician; 1987 Oct; 36(4):119-26. PubMed ID: 3314435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of hormonal therapy of fibrocystic breast disease.
    Dogliotti L; Fioretti P; Melis GB; Mussa A; Angeli A
    Ann N Y Acad Sci; 1986; 464():350-63. PubMed ID: 3089096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update in the therapy of fibrocystic mastopathy].
    Zanoio L; Zacché G; Mainenti M; Silvestre V
    Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects of fibrocystic disease of the breast. Treatment with danazol.
    Humphrey LJ; Estes NC
    Postgrad Med J; 1979; 55 Suppl 5():48-51. PubMed ID: 395520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial.
    Dogliotti L; Mansel RE
    Br J Clin Pract Suppl; 1989 Nov; 68():26-32; discussion 49-53. PubMed ID: 2488563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Danazol for treatment of fibrocystic mastopathy].
    von Fallois J; Etterli-Billenkamp U; Schindler EM; Schindler AE
    Zentralbl Gynakol; 1995; 117(9):457-65. PubMed ID: 7483879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF; de Freitas MM; Velludo MA
    Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
    Tobiassen T; Rasmussen T; Döberl A; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():159-76. PubMed ID: 6594009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Danol (danazol) in the treatment of fibrocystic breast disease with mastodynia].
    Lorenz I
    Cas Lek Cesk; 1989 Feb; 128(7):209-11. PubMed ID: 2720755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal management of fibrocystic disease of the breast.
    Andrews WC
    J Reprod Med; 1990 Jan; 35(1 Suppl):87-90. PubMed ID: 2404118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of fibrocystic mastopathy with danazol (100mg/day) studied by thermo-echo-clinical examination].
    Dambrosio F; Dibisceglia G; Colombo A
    Ann Ostet Ginecol Med Perinat; 1989; Spec No():44-57. PubMed ID: 2672980
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrocystic changes.
    Fiorica JV
    Obstet Gynecol Clin North Am; 1994 Sep; 21(3):445-52. PubMed ID: 7816405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
    Baranowska B; Stopińska-Głuszak U
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of danazol for benign breast disease.
    Baker HW; Snedecor PA
    Am Surg; 1979 Nov; 45(11):727-9. PubMed ID: 391113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of fibrocystic breast disease with danazol. A multicenter study].
    Fioretti P; Paoletti AM; Petacchi FD; Prato R; Mauro GA; Melis GB
    Minerva Ginecol; 1988 Jul; 40(7):427-33. PubMed ID: 3062500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrocystic disease of breast. Clinico-therapeutic considerations].
    Favia G; Lumachi F; D'Amico C; De Battisti S; Annunziata N; Berto M
    Minerva Chir; 1988 May; 43(9):759-62. PubMed ID: 3173746
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMPARISONS BETWEEN THE NON-PROLIFERATIVE AND PROLIFERATIVE THERAPY IN FIBROCYSTIC MASTOSIS.
    Carauleanu A; Socolov R; Rugina V; Gabia O; Carauleanu DM; Lupascu IA; Socolov D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):321-7. PubMed ID: 27483712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrocystic disorders of the breast].
    Tserotas K; Morán Villota C
    Ginecol Obstet Mex; 1998 Sep; 66():362-6. PubMed ID: 9789408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.